Transplantation· 2020Q1· Review
KDIGO Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation
- 692citations
- Q1SCImago
- 2020year
Short summary
This guideline provides updated, evidence-based recommendations for healthcare professionals worldwide on evaluating and managing potential kidney transplant candidates.
AI-generated from the title and abstract; the full text is not read.
Key points
- Provides updated guidance on evaluating and managing kidney transplant candidates.
- Addresses general candidacy, demographic, health status, and psychosocial factors.
- Details the assessment of various risk factors and comorbidities (e.g., diabetes, obesity, infections, cardiac disease).
- Emphasizes assimilating individual data within local health contexts for overall candidacy judgment.
- Recommendations are based on systematic reviews and the GRADE approach, noting evidence limitations.
AI-generated from the title and abstract; the full text is not read.
Abstract
The 2020 Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation is intended to assist health care professionals worldwide who evaluate and manage potential candidates for deceased or living donor kidney transplantation. This guideline addresses general candidacy issues such as access to transplantation, patient demographic and health status factors, and immunological and psychosocial assessment. The roles of various risk factors and comorbid conditions governing an individual's suitability for transplantation such as adherence, tobacco use, diabetes, obesity, perioperative issues, causes of kidney failure, infections, malignancy, pulmonary disease, cardiac and peripheral arterial disease, neurologic disease, gastrointestinal and liver disease, hematologic disease, and bone and mineral disorder are also addressed. This guideline provides recommendations for evaluation of individual aspects of a candidate's profile such that each risk factor and comorbidity are considered separately. The goal is to assist the clinical team to assimilate all data relevant to an individual, consider this within their local health context, and make an overall judgment on candidacy for transplantation. The guideline development process followed the Grades of Recommendation Assessment, Development, and Evaluation (GRADE) approach. Guideline recommendations are primarily based on systematic reviews of relevant studies and our assessment of the quality of that evidence, and the strengths of recommendations are provided. Limitations of the evidence are discussed with differences from previous guidelines noted and suggestions for future research are also provided.
The authors' abstract, as published at the source. Transplantation, 2020 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Transplantation
TransplantationMedicine